Jornadas held a new scientific session at SOLACI-SOCIME 2025

During the SOLACI-SOCIME 2025 Congress, the largest interventional cardiology event in Latin America, a notable scientific session was held, organized by the Jornadas SOLACI area, focused on the management of complex coronary artery disease. The session addressed key clinical and therapeutic aspects in the treatment of this type of disease and featured high-level speakers who shared their expertise and knowledge.

Jornadas SOLACI-SOCIME 2025

The session was coordinated by Ricardo Coloma (Peru) and included contributions from prominent specialists such as Gustavo Vignolo and Pablo Vázquez (Uruguay).

The program began with Erick Hornez (Bolivia), who presented Management of Left Main Coronary Artery Lesions: How Much Have We Learned?, updating the audience on the most effective strategies for treating these highly complex lesions. Next, Pedro Hidalgo (Venezuela) addressed Management of Calcified Lesions: What Tools Do We Have Today?, delving into the latest approaches and devices for treating calcified coronary artery lesions. Sebastián Lluberas (Uruguay) then presented The Drug-Coated Balloon and Its Current Indications, highlighting advancements in the use of drug-coated balloons and their applicability in coronary intervention.

The next presentation, by Gustavo Hidalgo (Ecuador), focused on Revascularization of Chronic Total Occlusions, outlining the most effective techniques for treating severe blockages in the coronary arteries. Finally, Pablo Vázquez (Uruguay) presented a Clinical Case, detailing a real-life challenge in the treatment of complex coronary artery disease, followed by an in-depth analysis of its resolution.

The session concluded with a discussion period, where the speakers exchanged insights and answered audience questions, reinforcing dialogue around the advances and challenges in the treatment of complex coronary artery disease.

This meeting highlighted the academic quality of the SOLACI-SOCIME 2025 Congress and reaffirmed the commitment of the Jornadas SOLACI area to continuing medical education and the ongoing development of healthcare professionals in interventional cardiology across Latin America.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...